Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Storage Instructions Approved For BYETTA®
Posted: Thursday, March 01, 2007
As reported in last week newsletter, it is no longer necessary to refrigerate the BYETTA® pen after you begin to use it, which will increase compliance dramatically.

New Possible Drug for Neuropathic Pain
Posted: Wednesday, February 21, 2007
Preliminary results from a phase III withdrawal-design trial with lacosamide in patients with painful diabetic neuropathy show that lacosamide was statistically significant over placebo in reducing pain scores. SCHWARZ PHARMA plans for regulatory submission during the second half of 2007.

Cause of Antipsychotic Drug Weight Gain Leading to Diabetes Found
Posted: Wednesday, February 21, 2007
Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.

New Oral Type 2 Drug Galvus as Effective as Avandia Without Weight Gain
Posted: Wednesday, February 21, 2007
The second of a new class of oral antidiabetic drugs is able to lower blood sugar (glucose) in type 2 diabetes as well as Avandia (rosiglitazone) does, but without causing weight gain.

Statin Therapy Associated With Reduction Of Atherosclerosis
Posted: Wednesday, February 14, 2007
An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis.

First Nonprescription Diet Drug Alli Wins U.S. Approval
Posted: Wednesday, February 14, 2007
At least 6 million Americans expected to buy Alli at a cost of 2 dollars a day, beginning this summer. For those that don’t reduce their fat intake while taking Alli, will be in for a surprise.

Avandia May Increase Risk for Hip and Other Fractures
Posted: Wednesday, February 14, 2007
Patients taking the diabetes drug Avandia may have a higher risk of hip and other fractures because the medicine decreases bone formation, according to new research by doctors in New Zealand.

Benefits of Chromium Picolinate In Diabetes Management
Posted: Thursday, February 08, 2007
In a peer-reviewed analysis, it was shown that chromium picolinate has a positive effect in improving glycemic control and lipids in Type 2 diabetes.

MannKind Corporation Will Submit for FDA Approval for It’s SUPRA Inhaled Insulin
Posted: Thursday, February 08, 2007
It has been described by Jay Skyler, a leading diabetologist, as the first in a new class of diabetic therapies, "Supra-Rapid Acting Insulin’s", that can change the way diabetes is treated.

Antidepressants Boost Insulin Sensitivity
Posted: Friday, February 02, 2007
Certain non-diabetic patients with major depressive disorder show improved insulin sensitivity following treatment with amitriptyline or paroxetine.

Page 95 of 119
 |<   <<   <  90  |  91  |  92  |  93  |  94  |  95  |  96  |  97  |  98  |  99  |  100  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement